|
Patients enrolled and fully evaluable
|
74 (100)
|
|
Age, median value (range, IQR)
|
72 (49–82, 67–77)
|
|
ECOG Performance Status
|
|
0–1
|
55 (74.3)
|
|
2
|
19 (25.7)
|
|
Gleason score
|
|
< 8
|
14 (22.2)
|
|
≥8
|
49 (77.8)
|
|
Unknown/missing
|
11
|
|
Bone mts
|
72 (97.3)
|
|
Visceral mts
|
11 (15.1)
|
|
Liver mts
|
6 (8.2)
|
|
Lymph node mts
|
42 (57.5)
|
|
Presence of pain
|
25 (36.8)
|
|
Previous surgery (radical prostatectomy)
|
33 (44.6)
|
|
Previous radiotherapy (radical radiotherapy)
|
32 (43.2)
|
|
Number of previous treatments
|
|
1
|
17 (23)
|
|
2
|
43 (58.1)
|
|
3
|
14 (18.9)
|
|
AR CN
|
|
Normal
|
40 (54.0)
|
|
Gain
|
34 (46.0)
|
|
Alkaline Phosphatase U/l, median value (range, IQR)
|
174 (54–965, 101–270)
|
|
Lactate Dehydrogenase U/l, median value (range, IQR)
|
240 (76–1177, 181–345)
|
|
Hemoglobin g/l, median value (range, IQR)
|
12.0 (9.0–15.0, 10.9–13.1)
|
|
Neutrophils count, median value (range, IQR)
|
4150 (840–8730, 3100–5360)
|
|
Lymphocytes count, median value (range, IQR)
|
1495 (90–26,000, 1120–1900)
|
|
Platelets count, median value (range, IQR)
|
236,000 (115,000–719,000, 196,000–295,000)
|
|
Serum Albumin g/l, median value (range, IQR)
|
31.3 (3.7–42.0, 4.0–40.0)
|
|
PSA, median value (range, IQR)
|
54.56 (2.69–5000, 19–175.60)
|
